Behandlung des Morbus Parkinson mit L-Dopa in Kombination mit einem Decarboxylasehemmer*
暂无分享,去创建一个
[1] G. C. Cotzias. Parkinsonism and dopa. , 1969, The New Zealand medical journal.
[2] George C. Cotzias,et al. Modification of Parkinsonism--chronic treatment with L-dopa. , 1969, The New England journal of medicine.
[3] R. Tissot,et al. Drug-induced changes of extracerebral dopa metabolism in man. , 1969, Archives of neurology.
[4] W. Burkard,et al. Increase of Cerebral Catecholamines caused by 3,4-Dihydroxyphenylalanine after Inhibition of Peripheral Decarboxylase , 1967, Nature.
[5] L. Schiffer,et al. Aromatic amino acids and modification of parkinsonism. , 1967, The New England journal of medicine.
[6] M. Greer,et al. Dopamine metabolism in Parkinson's disease , 1963, Neurology.
[7] P. Mcgeer,et al. Drug-induced extrapyramidal reactions. Treatment with diphenhydramine hydrochloride and dihydroxyphenylalanine. , 1961, JAMA.
[8] W. Wiederholt,et al. The use of l-dopa in parkinsonism. , 1969, The Ohio State medical journal.
[9] U. Rinne,et al. A Double Blind Study of l-Dopa Treatment in Parkinson's Disease , 1968 .